Kestra Medical Technologies, Ltd. (KMTS)
(Delayed Data from NSDQ)
$14.52 USD
-0.23 (-1.56%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $14.54 +0.02 (0.14%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Kestra Medical Technologies, Ltd. has a market cap of $757.39M, which represents its share price of $14.75 multiplied by its outstanding shares number of 51.35M. As a small-cap company, KMTS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
KMTS 14.52 -0.23(-1.56%)
Will KMTS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KMTS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for KMTS
KMTS Board Welcomes New Member Raymond Cohen
RxSight appoints Raymond Cohen to its board of directors
Wells Fargo Maintains Overweight Rating on KMTS, Lowers Price Target | KMTS Stock News
Kestra Medical Technologies Ltd.: Balanced Hold Rating Amid Revenue Growth and EBITDA Challenges
Kestra Stock Slips as Heavy Q4 Loss Overshadows Big Revenue Gains